Categorynews

Outlook on the 3D Printed Drugs Global Market to 2027 – by Dosage Forms, Technology and Geography – ResearchAndMarkets.com

October 5, 2020 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “3D Printed Drugs Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Dosage Forms; Technology, and Geography” report has been added to ResearchAndMarkets.com’s offering.

The 3D printed drugs market was valued at US$ 28.52 million in 2019 and is expected to grow at a CAGR of 9.1% from 2020 to 2027 to reach US$ 57.03 million by 2027. The factors driving the 3D printed drugs market growth include the increasing adoption of personalized medicines, extensive research and development activities, and growing prevalence of dysphagia. The illegal use of 3D printing for manufacturing of drugs hinders the growth of the market.

3D printed drugs are medications that are designed by 3D printing technique to provide safe and effective customized drugs to the individuals. These drugs have unitary porous structures that readily disperse in the mouth, thus ruling out the necessity to sallow high-dose medicines intact. It enables manufacturers to easily adjust the size, appearance, shape, and rate of the delivery of a wide array of medicines. The growth of 3D printed drugs market is prominently attributed to the increasing adoption of personalized medicines and extensively growing R& D activities related to 3D printing.

The implementation of 3D-printing technology to create personalized drug therapies is providing some exciting opportunities for improving patient care. Recent research has highlighted that more than 50% of consumers express interest in purchasing customized products or services. This demand will definitely lead to growth of the 3D printing market by 2027. Moreover, since the Precision Medicine’s Initiative was released in the US in 2015, pharmaceutical research organizations have been pursuing the development of more tailored treatments to make medicines safer and more effective.

(Read more…)

The advantages of 3D printing such as its ability to offer personalized medicine system with an automated control over drug dose and suitability for both low and high drug concentrations allow drug companies to attain boosted efficacy and adherence of drugs as well as focus on their brand longevity by expanding and capturing market share with other dosage forms. FabRx Ltd., completed the world’s first in-human clinical study using their proprietary Printlets technology, which relies on personalized 3D printed dosage forms to treat children with a rare metabolic disease. Additionally, in April 2020, the same company launched the first pharmaceutical 3D printer, M3DIMAKER, for the manufacture of personalized medicines. The technique of 3D printing drugs could help make the medication safer and more attractive to children.

The global 3D printed drugs market is segmented by dosage form and technology. The 3D printed drugs market, by dosage form, is segmented into tablets, capsules, multi drug implant, nanoparticles, solutions, and other dosage forms. The tablet segment held the largest share of the market, and it is expected to register the highest CAGR in the market during the forecast period. Based on technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, and stereo lithography (SLA). The zip dose held the largest share of technology segment in the global market; moreover, it is expected to register the fastest CAGR during the forecast period.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the 3D printed drugs market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global 3D printed drugs market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Market Dynamics

Drivers

  • Increasing Adoption of Personalized Drugs
  • Increasing Prevalence of Dysphagia

Restraints

  • Usage of 3D Printing to Develop Illegal Drugs

Opportunities

  • Rising Awareness About the 3D Printing Technology

Future Trends

  • Adoption of Novel Technologies in 3D Drugs Printing to Streamline Procedural Outcomes

Companies Mentioned

  • Aprecia Pharmaceuticals, LLC
  • FabRx LTD
  • Cycle Pharmaceuticals
  • GlaxoSmithKline Plc.
  • AstraZeneca
  • Tvasta
  • Merck KGGA

For more information about this report visit https://www.researchandmarkets.com/r/6a0tvw

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900